UKCapital Intelligence Plans
← Company directory

Later stage / growth

Artios Pharma

DNA damage response (oncology)

VerifiedSeries DCambridge
Companies House
09931309
GLEIF LEI
Not matched
Latest evidence
2025-11-01
Evidence snapshot
2026-08-25
Funding signal1

Dated disclosed rounds · latest 2025-11-01

Procurement signal0

Exact award notices · latest No exact award match

Registry observationMatched

2026-08-01

Regional contextEast

Jun 2026

Signals organise dated evidence; they do not score growth, revenue, creditworthiness or investment performance.

Evidence timeline

3 dated observations

Funding, procurement, registry and identifier records are placed on one chronology. Each row says whether it is a source fact, a record observation or reference metadata; no inferred event is inserted.

  1. RegistryRecord observation

    Status observed: Active

    Snapshot evidence only; this row does not claim the status changed on this date.

  3. RegistryRegistry fact

    Company incorporated

    ARTIOS PHARMA LIMITED · company 09931309

Latest disclosed round

Series D

Date
2025-11-01
Amount
USD 115m
Sector
Biotech & techbio
Companies House
09931309
ONS region
East

Evidence status

Directory ready

Identity
Verified
Match
High — exact company number and aligned registered name
Operating status
active
Data origins
Core directory, Growth Network, Live Chris T D1

Capital network

0 linked investors

Lead, participant, lender and other retained roles remain distinct where the source supports them. Every relationship below names its source layer, observation date, match method and publication state.

No investor relationship retained.

Funding record

1 disclosed round

Open a dated round to move directly between the company, named investors and source publication.

DateStageAmountInvestorsNamed sources
2025-11-01Series D$115M / €99M1 additional source-listed nameGlobenewswire ↗ · Globenewswire ↗

Companies House status and filing snapshot

ARTIOS PHARMA LIMITED

Exact company-number match from the public register. The retained status is active. Filing dates and SIC codes are registry context, not a credit or investment-quality assessment.

Registered record

Status
Active
Company type
Private Limited Company
Country of origin
United Kingdom
Incorporated
2015-12-29
Dissolved
Not applicable
Company number
09931309

Filing context

Accounts category
GROUP
Accounts made up to
2024-12-31
Next accounts due
2026-09-30
Confirmation made up to
2025-12-28
Registry snapshot
2026-08-01
Live check
Bulk snapshot only
72110Research and experimental development on biotechnology

SourceCompanies HouseDate2026-08-01Matchexact Companies House numberStatepublished projection

Companies House ↗Registry report →

Traceability

Source trail

Funding and investor claims retain named public-source links. This is a dated research snapshot, not a live cap table.